Global Hernia Mesh Repair Devices Market is expected to reach USD 5,952.26 million by 2024 from USD 4,170.27 million in 2016, at a CAGR of 4.7%. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
The global hernia mesh repair devices market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. The global hernia mesh repair devices market is dominated Johnson & Johnson Services, Inc., followed by Medtronic and B. Braun Melsungen. Other players in this market include C R BARD, INC, W.L GORE & ASSOCIATES, INC, ATRIUM, ACELITY L.P. INC, among others holds 31.6% of the global hernia mesh repair devices market in 2016.
JOHNSON & JOHNSON SERVICES INC:
Founded in 1886 and headquartered at New Brunswick, New Jersey, U.S., Johnson & Johnson Services, Inc.is involved in multinational medical devices, pharmaceutical and consumer packaged goods manufacturing. The company operates through three business segments- Consumer, Pharmaceutical, and Medical Devices. The pharmaceutical segment offers a wide range of products for five major therapeutic applications—immunology, infectious diseases, neuroscience, oncology, and cardiovascular & metabolic diseases. The consumer segment of the company offers various products pertaining to baby care, oral care, skin care, women’s health, and wound care. The medical devices segment of the company offers various devices to be used in therapeutic areas such as orthopedic, surgical care, specialty surgery, cardiovascular care, diagnostics, diabetes care, and vision care.
Johnson & Johnson has more than 265 operating companies across the United States, Europe, Western Hemisphere, Africa, and Asia-Pacific. Ethicon US, LLC., subsidiary of Johnson & Johnson Services, Inc. is engaged in the development and marketing of healthcare products. Some of its subsidiaries include Janssen Pharmaceuticals (Belgium), Ethicon Inc. (U.S.), DePuy (U.S.), Neutrogena (U.S.), Synthes (Switzerland), Cordis Corporation (U.S.), LifeScan, Inc. (U.S.), Janssen-Cilag (U.S.), McNeil Consumer Healthcare (U.S.), Janssen Biotech, Inc. (U.S.), Ortho Clinical Diagnostics (U.S.), and Mentor Worldwide LLC (U.S.)..
Founded in 1949 and headquartered in Minneapolis, U.S.. Medtronic is the world’s largest standalone medical technology development and a global healthcare solution company. The company operates in cardiac and vascular group (cardiac rhythm and heart failure, coronary and structural heart, aortic and peripheral vascular), minimally invasive therapies group (surgical solutions and patient monitoring & recovery), restorative therapies (spine, brain therapies, speciality therapies and pain therapies), and diabetes group (intensive insulin management, non- intensive diabetes therapies, Diabetes service and solutions).
The company operates in more than 155 countries worldwide with more than 260 locations in research and development, manufacturing and distribution, and education centers. The company’s regional locations are Asia Pacific, Eastern Europe, Latin America, Middle East and Africa, Central Asia, South Asia, North America, and Western Europe. Some of its subsidiaries include Medtronic Belgium S.A./N.V. (Belgium), Dantec Elettronica S.r.l. (Rome), Medtronic (Shanghai) Ltd. (China), Medtronic B.V. (Netherlands), Medtronic Xomed Limited (U.K) and many more
Braun Melsungen AG:
Global Hernia Mesh Repair Devices Market – Industry Trends and Forecast to 2026
Europe Hernia Mesh Repair Devices Market – Industry Trends and Forecast to 2027
U.S. Hernia Mesh Repair Devices Market - Industry Trends and Forecast to 2027
North America Hernia Mesh Repair Devices Market - Industry Trends and Forecast to 2027
Asia-Pacific Hernia Mesh Repair Devices Market – Industry Trends and Forecast to 2024